550.90
-14.80
(-2.62%)
At close: January 27 at 3:29:00 PM GMT+5:30
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Sanjeev Jain | Co-Founder, MD & Whole Time Director | -- | -- | 1966 |
| Mr. Sandeep Jain | Co Founder, MD & Director | -- | -- | 1967 |
| Mr. Sumeet Sood | Chief Financial Officer | -- | -- | -- |
| Mr. Sanjay Kumar Sinha | President of Operations & Whole Time Director | -- | -- | 1958 |
| Mr. Dharamvir Malik | Company Secretary & Compliance Officer | -- | -- | -- |
| Mr. Arvind Srivastava | President of Human Resource | -- | -- | -- |
| Mr. Sanjay Sharma | President of Strategy, New Projects & Business Excellence | -- | -- | -- |
| Mr. Amrut Medhekar | Chief Executive Officer - CDMO Business | -- | -- | -- |
| Mr. Shantanu R. Chobhe | Corporate Quality Assurance Head | -- | -- | -- |
| Mr. Jitendra Mishra | Vice President of Information Technology of PCHL | -- | -- | -- |
Akums Drugs and Pharmaceutical
Plot no. 131 to 133, Block C
Mangolpuri, Industrial Area Phase 1
Delhi, 110083
India
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 7,388
Description
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. It offers dosage forms, such as tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form fill seals, topical preparations, eye drops, dry powder injections, rotacaps and gummies, and others. The company operates as pharmaceutical contract development and manufacturing company. It also sells branded pharmaceutical formulations. The company was incorporated in 2004 and is based in Delhi, India.
Corporate Governance
Akums Drugs and Pharmaceutical’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available